ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma
2020 · Theranostics · 148 citations
https://doi.org/10.7150/thno.41498
L
Luqing Tong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
44
Papers
784
Citations
15
h-index
19
i10-index
Luqing Tong is an academic researcher from First Affiliated Hospital Zhejiang University. The author has contributed to research in topics: Glioma Diagnosis and Treatment & MicroRNA in disease regulation & Ferroptosis and cancer prognosis. The author has an h-index of 15, co-authored 38 publications.
ORCID: 0000-0003-0203-037XPapers by this author
worksTMEM158 promotes the proliferation and migration of glioma cells via STAT3 signaling in glioblastomas
2022 · Cancer Gene Therapy · 45 citations
https://doi.org/10.1038/s41417-021-00414-5
The interactome and spatial redistribution feature of Ca2+ receptor protein calmodulin reveals a novel role in invadopodia-mediated invasion
2018 · Cell Death and Disease · 37 citations
https://doi.org/10.1038/s41419-017-0253-7
PDPN contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma
2022 · Cancer Gene Therapy · 19 citations
https://doi.org/10.1038/s41417-022-00550-6
Immunological and clinicopathological characteristics of C1RL in 2120 glioma patients
2020 · BMC Cancer · 13 citations
https://doi.org/10.1186/s12885-020-07436-6
Proteomics shows that brain metastases of lung adenocarcinoma overexpress ribosomal proteins in response to gamma knife radiosurgery
2024 · Scientific Reports · 3 citations
https://doi.org/10.1038/s41598-024-58967-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat